Links:

Dateien herunterladen:

Weitere Literatur, soweit nicht oben dargestellt.

Aronia:

P2: Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses.

Aronia melanocarpa und ihre Bestandteile zeigen antivirale Aktivität gegen Influenzaviren.

Article in  Biochemical and Biophysical Research Communications 440(1) · September 2013

DOI: 10.1016/j.bbrc.2013.08.090 · Source: PubMed

Cistus:

P3: Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract: A prospective, randomised, placebo-controlled clinical study. Cistus incanus (CYSTUS052) zur Behandlung von Patienten mit Infektionen der oberen Atemwege: Eine prospektive, randomisierte, placebokontrollierte klinische Studie.

Ulrich Kalus Alexandre Grigorov Oliver Kadecki Jan PeterJansen Holger Kiesewetter Hartmut Radtke Institut für Transfusionsmedizin, Charité - Universitaetsmedizin Berlin, Campus Charité Mitte, D-10098 Berlin, Germany

Journal of Medicinal Plants Research Vol. 3(13), pp. 1189-1195, December, 2009; Antiviral Research Volume 84, Issue 3, December 2009, Pages 267-271; doi: 10.1016/j.antiviral.2009.10.001. Epub 2009 Oct 12. https://pubmed.ncbi.nlm.nih.gov/19828122/

Eukalyptus:

P4: Early Viral Clearance among Covid-19Patients When Gargling with Povidone-Iodine and Essential Oils – A Clinical Trial. Frühzeitige Beseitigung von Viren bei Covid-19-Patienten beim Gurgeln mit Povidon-Jod und ätherischen Ölen - eine klinische Studie.  Nurul Azmawati Mohamed et.al.    medRxiv preprint https://doi.org/10.1101/2020.09.07.20180448 

Grüntee & Schwarzer Tee:

P5: Significant inactivation of SARS-CoV-2 by a green tea catechin, a catechin-derivative and galloylated theaflavins in vitro

Signifikante Inaktivierung von SARS-CoV-2 durch ein Grüntee-Catechin, ein Catechin-Derivat und galloylierte Theaflavine in vitro

Eriko Ohgitani, Masaharu ShinYa, Masaki Ichitani, Makoto Kobayashi, Takanobu Takihara, Masaya Kawamoto, Hitoshi Kinugasa, Osam Mazda   https://doi.org/10.1101/2020.12.04.412098

P6: EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro EGCG, ein Polyphenol aus grünem Tee, hemmt die Vermehrung des menschlichen Coronavirus in vitro

Jang, Minsu; Park, Rackhyun; Park, Yea-In; Cha, Yeo-Eun; Yamamoto, Ayane; Lee, Jin I.; Park, Junsoo;   

Biochemical and Biophysical Research Communications; 2021

https://www.sciencedirect.com/science/article/pii/S0006291X21001935

P7: Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Strukturelle und funktionelle Grundlagen des Eindringens von SARS-CoV-2 unter Zuhilfenahme von menschlichem ACE2.

Wang, Qihui; Zhang, Yanfang; Wu, Lili; Niu, Sheng; Song, Chunli; Zhang, Zengyuan et al. (2020):

In: Cell 181 (4), 894-904.e9.   DOI: 10.1016/j.cell.2020.03.045.

P8: Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro.

Die Tee-Polyphenole EGCG und Theaflavin hemmen die Aktivität der 3CL-Protease von SARS-CoV-2 in vitro.

Jang, Minsu; Park, Yea-In; Cha, Yeo-Eun; Park, Rackhyun; Namkoong, Sim; Lee, Jin I. et al. (2020):

In: Evidence-Based Complementary and Alternative Medicine 2020, S. 5630838.  DOI: 10.1155/2020/5630838.

P9: Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases

Therapeutisches Potenzial von EGCG, einem Polyphenol aus grünem Tee, zur Behandlung von Coronavirus-Erkrankungen

Park, Junsoo; Park, Rackhyun; Jang, Minsu; Park, Yea-In (2021): (Life, 11).              DOI: 10.3390/life11030197

P10: Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 Receptor. Epigallocatechingallat aus grünem Tee blockiert wirksam die Infektion von SARS-CoV-2 und neuen Varianten durch Hemmung der Spike-Bindung an den ACE2-Rezeptor.

Liu, Jinbiao; Bodnar, Brittany H.; Meng, Fengzhen; Khan, Adil; Wang, Xu; Luo, Guangxiang et al. (2021):

In: bioRxiv, 2021.03.17.435637. DOI: 10.1101/2021.03.17.435637.

P11: COVID -19: could green tea catechins reduce the risks? COVID-19: Können Grüntee-Katechine die Risiken verringern?

Storozhuk, M.: doi: https://doi.org/10.1101/2020.10.23.20218479 https://www.medrxiv.org/content/10.1101/2020.10.23.20218479v3

P12: A Review of the Antiviral Role of Green Tea Catechins   Ein Überblick über die antivirale Rolle von Grüntee-Katechinen

Jun Xu,* Zhao Xu, and Wenming Zheng; Journal of Medicinal Plants Research Vol. 3(13), pp. 1189-1195, December, 2009 Available online at http://www.academicjournals.org/JMPR ISSN 1996-0875© 2009 Academic Journals; Molecules. 2017 Aug; 22(8): 1337.

Published online 2017 Aug 12. doi: 10.3390/molecules22081337; PMCID: PMC6152177        PMID: 28805687

P13: Review: The use of herbal extracts in the control of influenza   Übersicht: Die Verwendung von Pflanzenextrakten bei der Bekämpfung der Influenza

James B. Hudson Department of Pathology and Laboratory Medicine, University of British, Columbia, Vancouver, Canada. E-mail: jbhudson@interchange.ubc.ca. Tel: 1-604-948-2131. Fax: 1-604-875-4351.

P14: Review: Tea catechins as a potential alternative anti-infectious agent   Übersicht: Teekatechine als potenzielles alternatives Antiinfektivum   Jae Min Song and Baik Lin Seong   10.1586/14787210.5.3.497   www.future-drugs.com     Expert Rev. Anti Infect. Ther. 5(3), 497–506 (2007)

P15: Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure–activity relationship analysis   Vergleich der antiviralen In-vitro-Aktivität von Tee-Polyphenolen gegen Influenza-A- und -B-Viren und Analyse der Struktur-Wirkungsbeziehung    Fitoterapia  Volume 93, March 2014, Pages 47-53

P16: Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review 

Antivirale Aktivität von Grüntee- und Schwarztee-Polyphenolen zur Prophylaxe und Behandlung von COVID-19: Eine Übersicht 

Susmit Mhatre, Tishya Srivastava, Shivraj Naik, Vandana Patravale:    https://doi.org/10.1016/j.phymed.2020.153286

P17: Review Tea catechins as a potential alternative anti-infectious agent   Übersicht Tee-Katechine als potenzielles alternatives Antiinfektionsmittel   Jae Min Song and Baik Lin Seong  10.1586/14787210.5.3.497   www.future-drugs.com     Expert Rev. Anti Infect. Ther. 5(3), 497–506 (2007)

P18: Efficacy of a Polyphenolic, Standardized Green Tea Extract for the Treatment of COVID-19 Syndrome: A Proof-of-Principle Study. Wirksamkeit eines polyphenoli-angereicherten, standardisierten Grüntee-Extrakts bei der Behandlung des COVID-19-Syndroms: Eine Proof-of-Principle-Studie. Bettuzzi, S.; Gabba, L.; Cataldo, S. ; COVID 2021, 1, 2–12.    https://doi.org/10.3390/covid1010002

Granatapfel:

Tito, Annalisa; Colantuono, Antonio; Pirone, Luciano; Pedone, Emilia; Intartaglia, Daniela; Giamundo, Giuliana; Conte, Ivan; Vitaglione, Paola; Apone, Fabio:

P19: Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs

Front. Chem., 28 April 2021 DOI: 10.3389/fchem.2021.638187; https://www.frontiersin.org/article/10.3389/fchem.2021.638187

P20: Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir

MehranHaidariabMuzammilAliaSamuelWard CasscellsIIIab

https://doi.org/10.1016/j.phymed.2009.06.002

Journal of Medicinal Plants Research Vol. 3(13), pp. 1189-1195, December, 2009 Available online at http://www.academicjournals.org/JMPR ISSN 1996-0875© 2009 Academic Journals

Holunderbeeren:

P21: Randomized Study of the Efficacy and Safety of Oral Elderberry Extract in the Treatment of Influenza A and B Virus Infections

ZAKAY-RONES1, E THOM2, T WOLLAN3ANDJ WADSTEIN41Department of Virology, Hebrew University-Hadassah Medical School, Jerusalem, Israel;

2PAREXEL Norway AS, PO Box 210, N-2001 Lillestrøm, Norway; 3Jernbanealléen 30, N-3210Sandefjord, Norway; 4Østra Rønneholmsv 6B, 21147 Malmö, Sweden

https://doi.org/10.1177/147323000403200205

P22: Review The use of herbal extracts in the control of influenza

James B. Hudson Department of Pathology and Laboratory Medicine, University of British, Columbia, Vancouver, Canada. E-mail: jbhudson@interchange.ubc.ca. Tel: 1-604-948-2131. Fax: 1-604-875-4351.